Trials / Available
AvailableNCT07000695
Managed Access Programs for TQJ230, Pelacarsen
- Status
- Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this registration is to list Managed Access Programs (MAPs) related to TQJ230, pelacarsen
Detailed description
CTQJ230A12013M - Available - Managed Access Program (MAP) Cohort Treatment Plan (CTQJ230A12013M) to provide access to pelacarsen (TQJ230) for (Atherosclerotic Cardiovascular Disease, ASCVD)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pelacarsen | Patients receive Pelacarsen |
Timeline
- First posted
- 2025-06-03
- Last updated
- 2025-06-03
Source: ClinicalTrials.gov record NCT07000695. Inclusion in this directory is not an endorsement.